Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sharon Shacham Insider Profile
18 Followers
Sharon Shacham, CSO at Karyopharm Therapeutics, holds 1.67M shares in Karyopharm Therapeutics (Ticker: KPTI), holds ― shares in Acrivon Therapeutics, Inc. (Ticker: ACRV).
Profitable Transactions
7 out of 7 Profitable Transactions
Average Return
+48.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sharon Shacham holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 13, 2015 - Jan 13, 2016
Return:+75.60%
The most profitable trade made by Sharon Shacham
Sharon Shacham's Trading History
Karyopharm Therapeutics
Mar 31, 2022
CSO
Uninformative Buy
―
$1.67M
Acrivon Therapeutics, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Sharon Shacham's performance on stock
You May Also Like
Sharon Shacham insider profile FAQ
What is the percentage of profitable transactions made by Sharon Shacham?
The percentage of profitable transactions made by Sharon Shacham is 100%.
What is the average return per transaction made by Sharon Shacham?
The average return per transaction made by Sharon Shacham is 48.60%.
What stocks does Sharon Shacham hold?
Sharon Shacham holds: KPTI, ACRV stocks.
What was Sharon Shacham’s latest transaction?
Sharon Shacham latest transaction was an Uninformative Buy of ―.
What was Sharon Shacham's most profitable transaction?
Sharon Shacham’s most profitable transaction was an Informative Sell of KPTI stock on January 13, 2015. The return on the trade was 75.60%.
What is Sharon Shacham's role in Karyopharm Therapeutics?
Sharon Shacham's role in Karyopharm Therapeutics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.